$17.80
1.08%
NYSE, Sep 25, 04:25 pm EDT. Closed.
ISIN
US49177J1025
Symbol
KVUE

Kenvue Stock price

$17.80
-1.53 7.92% 1M
+0.14 0.79% 6M
+0.55 3.19% YTD
+1.63 10.08% 1Y
-3.03 14.55% 3Y
-9.10 33.83% 5Y
-9.10 33.83% 10Y
-9.10 33.83% 20Y
NYSE, Closing price Fri, Sep 25 2026
+0.19 1.08%
ISIN
US49177J1025
Symbol
KVUE
Index

AI Insights on Kenvue Insights AI Insights on Kenvue

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Is Kenvue a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
$34.2b
Enterprise Value
$41.6b
Net debt
$7.4b
Cash
$1.1b
Shares outstanding
1.9b
Valuation (TTM | estimate)
P/E
20.7
P/S
2.2 | 2.1
EV/Sales
2.7 | 2.6
EV/FCF
21.7
P/B
3.2
Dividends
DPS
$0.84
Yield 1Y | 5Y
4.7% | 2.8%
Growth 1Y | 5Y
1.2% | -
Payout 1Y | 3Y
108.6% | 92.5%
Increased
4 Years
Financials (TTM | estimate)
Revenue
$15.4b | $15.9b
EBITDA
$3.6b
EBIT
$3.0b
Net Income
$1.7b
Free Cash Flow
$1.9b
Growth (TTM | estimate)
Revenue
1.8% | 5.3%
EBITDA
9.8%
EBIT
13.7%
Net Income
16.9%
Free Cash Flow
17.2%
Margin
Gross
58.6%
EBITDA
23.1%
EBIT
19.4%
Net
10.8%
Free Cash Flow
12.4%
Financial Health
Equity Ratio
39.8%
Return on Equity
13.7%
ROCE
14.3%
ROIC
9.7%
Debt/Equity
0.8
More
EPS
$0.9
FCF per Share
$1.0
Short interest
4.4%
Employees
22k
Rev per Employee
$690.0k

Kenvue Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Kenvue forecast:

6x Buy
30%
14x Hold
70%

Analyst Opinions

20 Analysts have issued a Kenvue forecast:

Buy
30%
Hold
70%

Financial data from Kenvue

Jun '26
+/-
%
15,408 15,408
2% 2%
100%
- Direct Costs 6,373 6,373
1% 1%
41%
9,035 9,035
2% 2%
59%
- Selling and Administrative Expenses 5,471 5,471
5% 5%
36%
- Research and Development Expense 557 557
42% 42%
4%
3,560 3,560
10% 10%
23%
- Depreciation and Amortization 567 567
7% 7%
4%
EBIT (Operating Income) EBIT 2,993 2,993
14% 14%
19%
Net Profit 1,658 1,658
17% 17%
11%

In millions USD.

Don't miss a Thing! We will send you all news about Kenvue directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Kenvue Stock News

Neutral
Reuters
●
4 days ago
Kimberly-Clark has offered concessions to address EU antitrust concerns about its $40 billion ​bid for Tylenol maker Kenvue , a filing ‌on the European Commission website showed on Wednesday.
Neutral
Reuters
●
13 days ago
Kimberly-Clark is readying concessions to address ​EU antitrust concerns about ‌its bid for Tylenol maker Kenvue that could help ​it win approval ​for the $40 billion deal after ⁠a preliminary review, ​people familiar with the matter ​said.
Neutral
ETF Trends
●
14 days ago
Owning consumer staples stocks is an absolute must in a dividend investing strategy. Most people turn to dividend stocks for two reasons — to generate income or to put the magic of compounding to work using dividend reinvestment to amplify wealth building over time.
More Kenvue News

Company Profile

Kenvue, Inc. engages in the provision of healthcare products services. It operates through the following business segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care and hair, sun and others. The Essential Health segment includes oral care, baby care, women’s health and wound care. The company was founded on February 23, 2022 and is headquartered in Skillman, NJ.

Head office United States
CEO Mr. Perry
Employees 21,890
Website www.kenvue.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today